Understanding your insurance coverage is very important. Our
CareConnectPSS® Case Managers are here to help you better understand your
insurance benefits, so you can get access to the treatment you need.
Linda and Alan, USA,
patients with Gaucher disease type 1 treated with Cerdelga
Get access to the treatment you need. Sanofi Genzyme offers copay assistance and charitable access programs for eligible patients.
The CareConnectPSS Copay Program helps eligible, US patients who are prescribed one of Sanofi Genzyme’s treatments pay for eligible, out-of-pocket, drug-related expenses, including copays, coinsurance, and deductibles.
The program is open to individuals who:
The program is not valid for prescriptions eligible to be reimbursed, in whole or in part, by Medicaid, Medicare (including Medicare Part D), or other federal or state programs (including any state prescription drug assistance programs).
Complete an online enrollment application form. Your application will be reviewed for eligibility. If you are eligible, you will be automatically enrolled in the program. If eligible, you will receive your copay card within 7-10 days.
For questions or to learn more about the program, call your CareConnectPSS Case Manager at this 1-800-745-4447, option 3.
*The CareConnectPSS Copay Program is available only in the United States and cannot be combined with any other rebate/coupon, free trial, or similar offer. Copay benefits are not transferable. This program assists patients with their out-of-pocket drug costs for their prescribed Sanofi Genzyme treatment only and does not cover or provide support for the cost of MD office visits/evaluations, nursing services/observation periods, blood work, x-rays or other testing, premedications/other medications, EpiPens, transportation or other related services. No claim for reimbursement of any out-of-pocket expense covered by the CareConnectPSS Copay Program may be submitted to any third-party payer, where public or private. Sanofi Genzyme reserves the right to make eligibility decisions, set program maximums, and rescind, revoke, or amend this program without notice.
This program was established in the US to provide Sanofi Genzyme’s therapies to eligible individuals who do not have health insurance or have inadequate coverage for treatment. It is considered a temporary solution until long-term coverage can be secured.
The Sanofi Genzyme Charitable Access Program has been established in the United States through the Genzyme Charitable Foundation, Inc. The program is committed to providing Cerdelga to individuals who:
Qualified individuals with Gaucher disease type 1 whose physicians have recommended treatment with Cerdelga may be eligible for the Charitable Access Program. If a patient is ineligible for our program, their CareConnectPSS Case Manager will work with the patient and their health care providers to explore alternative coverage options.
To be considered for the program, you will be asked to provide the following:
A CareConnectPSS Case Manager will coordinate with you and your physician to obtain the necessary documentation, including a signed waiver, and keep you updated on the status of your patient’s application. Applications are reviewed on a monthly basis and are kept confidential by the Sanofi Genzyme Charitable Access Program.
Please note that the Sanofi Genzyme Charitable Access Program is considered a temporary program. Patients and their families are expected to continue exploring alternative resources with the assistance of a CareConnectPSS Case Manager. These may include:
To learn more about the Sanofi Genzyme Charitable Access Program or to request an application form, call 1-800-745-4447, Option 3.
The Sanofi Genzyme Charitable Access Program may be discontinued at any time at the discretion of The Charitable Access Program Committee.